The data showed that Moderna vaccine recipients had fewer breakthrough infections and hospitalizations than did Pfizer recipients.
But there was no "statistically significant" difference in mortality rates.
The data showed that Moderna vaccine recipients had fewer breakthrough infections and hospitalizations than did Pfizer recipients.
But there was no "statistically significant" difference in mortality rates.